AQP4 and neuromyelitis optica: In wild type mice, when patient-derived AQP4-IgGs were intracerebrally injected acutely with human complement, matured NMO pathology including AQP4 and GFAP loss, myelin damage, complement deposition, and axon injury was observed (59).